Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Canaccord Genuity raises target price on Clarkson

(Sharecast News) - Analysts at Canaccord Genuity hiked their target price on shipping firm Clarkson from 4,300.0p to 4,500.0p on Tuesday, stating the firm was "well-positioned" to ride out volatility. Canaccord Genuity said trading has been supportive, with Clarkson's weighted forward order book delivering H2 weighted profits. As FY24 draws to a close, the analysts reckon Clarkson will have tripled pre-tax profits since FY19.

The Canadian bank also noted that unless Clarkson looks to move on any M&A activity or make larger internal investments, it sees higher than consensus dividend per share payouts. It also sees further scope for upside to its target price should Clarkson reinvest surplus cash into the careful expansion of its roughly 19% RoE business.

"Beyond FY24E, we think broker FOBs signal better ahead and evidence of a long-term potential super cycle as we see limited yard capacity (barely sufficient to replace ~2-3% of the global fleet p.a.) and the need for accelerated new build requirements to meet increasingly stringent environmental regulations," said Canaccord, which reiterated its 'buy' rating on the stock.

"We think share price upside factors include: 1) 'Show me' of DPS payout uplift, as we believe that DPS is a key share price driver (Fig. 6) but payout is low (FY23 at 37% vs. 2013-2021's 59%); and, 2) increasing proportion of ARR (and duration), which potentially exerts upward PER pressure."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

ConocoPhillips to buy 42% stake in BP Iraq oil fields
(Sharecast News) - BP said on Friday that it has agreed terms for ConocoPhillips to buy a 42% interest in BP Energy Company of Kirkuk (BP ECKL).
GSK shares fall as cough drug development axed
(Sharecast News) - Shares in GSK fell sharply on Friday after the pharma titan announced it was stopping the development of a refractory chronic cough drug after unsuccessful results late-stage clinical trial.
Deutsche Bank downgrades Rotork after ABB takeover
(Sharecast News) - Deutsche Bank downgraded Rotork on Friday to 'hold' from 'buy' and lifted the price target to 503p from 400p after it agreed to be bought by Swiss engineering firm ABB in a £4.1bn deal.
Wise Q1 revenues rise as customer numbers grow
(Sharecast News) - Wise reported an increase in first-quarter revenue on Friday as customer numbers at the money transfer firm rose.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.